67 related articles for article (PubMed ID: 21370421)
1. Acute megakaryoblastic leukemia with a four-way variant translocation originating the RBM15-MKL1 fusion gene.
Torres L; Lisboa S; Vieira J; Cerveira N; Santos J; Pinheiro M; Correia C; Bizarro S; Almeida M; Teixeira MR
Pediatr Blood Cancer; 2011 May; 56(5):846-9. PubMed ID: 21370421
[TBL] [Abstract][Full Text] [Related]
2. Acute Megakaryoblastic Leukemia with t(1;22) Mimicking Neuroblastoma in an Infant.
Gökçe M; Aytaç S; Ünal Ş; Altan İ; Gümrük F; Çetin M
Turk J Haematol; 2015 Mar; 32(1):64-7. PubMed ID: 25805677
[TBL] [Abstract][Full Text] [Related]
3. A retrospective analysis of gene fusions and treatment outcomes in pediatric acute megakaryoblastic leukemia without Down syndrome.
Suzuki K; Hama A; Okuno Y; Xu Y; Narita A; Yoshida N; Muramatsu H; Nishio N; Kato K; Kojima S; Yoo KH; Takahashi Y
Haematologica; 2024 Jun; 109(6):1936-1940. PubMed ID: 38299674
[No Abstract] [Full Text] [Related]
4. Acute megakaryoblastic leukemia in a pediatric patient.
Strasser B; Haushofer A
Hematol Transfus Cell Ther; 2024; 46(3):321-322. PubMed ID: 38123377
[No Abstract] [Full Text] [Related]
5. The genomic landscape of acute lymphoblastic leukemia in children and young adults.
Mullighan CG
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):174-80. PubMed ID: 25696852
[TBL] [Abstract][Full Text] [Related]
6. Detection of RBM15-MKL1 fusion was useful for diagnosis and monitoring of minimal residual disease in infant acute megakaryoblastic leukemia.
Takeda A; Shimada A; Hamamoto K; Yoshino S; Nagai T; Fujii Y; Yamada M; Nakamura Y; Watanabe T; Watanabe Y; Yamamoto Y; Sakakibara K; Oda M; Morishima T
Acta Med Okayama; 2014; 68(2):119-23. PubMed ID: 24743787
[TBL] [Abstract][Full Text] [Related]
7. Acute megakaryoblastic leukemia with t(1;22)(p13.3;q13.1); RBM15-MKL1 mimicking hepatoblastoma in an infant: The role of karyotype in differential diagnosis.
Marques-Piubelli ML; Cordeiro MG; Cristofani L; Barroso RS; Paes VR; Castelli JB; Rodrigues Pereira Velloso ED
Pediatr Blood Cancer; 2020 Mar; 67(3):e28111. PubMed ID: 31802626
[No Abstract] [Full Text] [Related]
8. Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study.
de Rooij JD; Masetti R; van den Heuvel-Eibrink MM; Cayuela JM; Trka J; Reinhardt D; Rasche M; Sonneveld E; Alonzo TA; Fornerod M; Zimmermann M; Pigazzi M; Pieters R; Meshinchi S; Zwaan CM; Locatelli F
Blood; 2016 Jun; 127(26):3424-30. PubMed ID: 27114462
[TBL] [Abstract][Full Text] [Related]
9. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.
de Rooij JD; Branstetter C; Ma J; Li Y; Walsh MP; Cheng J; Obulkasim A; Dang J; Easton J; Verboon LJ; Mulder HL; Zimmermann M; Koss C; Gupta P; Edmonson M; Rusch M; Lim JY; Reinhardt K; Pigazzi M; Song G; Yeoh AE; Shih LY; Liang DC; Halene S; Krause DS; Zhang J; Downing JR; Locatelli F; Reinhardt D; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M; Gruber TA
Nat Genet; 2017 Mar; 49(3):451-456. PubMed ID: 28112737
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
[TBL] [Abstract][Full Text] [Related]
11. RBM15 Functions in Blood Diseases.
Hu M; Yang Y; Ji Z; Luo J
Curr Cancer Drug Targets; 2016; 16(7):579-85. PubMed ID: 26758534
[TBL] [Abstract][Full Text] [Related]
12. Acute megakaryoblastic leukaemia with t(1;22)(p13·3;q13·1)/RBM15-MKL1 in an adult patient following a non-mediastinal germ cell tumour.
Saito Y; Makita S; Chinen S; Kito M; Fujino T; Ida H; Hosoba R; Tanaka T; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Miyagi-Maeshima A; Matsushita H; Izutsu K
Br J Haematol; 2020 Sep; 190(6):e329-e332. PubMed ID: 32572949
[No Abstract] [Full Text] [Related]
13. Hemophagocytosis by leukemic megakaryoblasts in acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1.
Wiseman DH; Bonney DK; Wynn RF
J Pediatr Hematol Oncol; 2012 Oct; 34(7):576-80. PubMed ID: 22469944
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer.
Zhang C; Gu L; Xiao J; Jin F
BMC Cancer; 2023 Jul; 23(1):684. PubMed ID: 37474926
[TBL] [Abstract][Full Text] [Related]
15. RBM15 silencing promotes ferroptosis by regulating the TGF-β/Smad2 pathway in lung cancer.
Feng J; Li Y; He F; Zhang F
Environ Toxicol; 2023 Mar; 38(4):950-961. PubMed ID: 36715115
[TBL] [Abstract][Full Text] [Related]
16. Circ-CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15.
Yang F; Liu Y; Xiao J; Li B; Chen Y; Hu A; Zeng J; Liu Z; Liu H
Cell Prolif; 2023 Jan; 56(1):e13344. PubMed ID: 36181462
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of N6-methyladenosine RBM15 regulators in lung adenocarcinoma.
Ma M; Wang W; Wang B; Yang Y; Huang Y; Zhao G; Ye L
Cell Mol Biol (Noisy-le-grand); 2022 May; 68(1):130-139. PubMed ID: 35809319
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.
Zeng X; Chen K; Li L; Tian J; Ruan W; Hu Z; Peng D; Chen Z
Free Radic Biol Med; 2022 May; 184():135-147. PubMed ID: 35381326
[TBL] [Abstract][Full Text] [Related]
19. Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.
Zhang Z; Mei Y; Hou M
Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
[TBL] [Abstract][Full Text] [Related]
20. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]